Reference : The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogen...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/192118
The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice.
English
Cao, Martine mailto [Dartmouth Medical School > > > >]
Royce, Darlene B. [> >]
Risingsong, Renee [> >]
Williams, Charlotte R. [> >]
Sporn, Michael B. [> >]
Liby, Karen T. [> >]
2016
Cancer prevention research (Philadelphia, Pa.)
9
1
105-14
Yes (verified by ORBi)
International
1940-6215
1940-6215
United States
[en] LG101506 was originally synthesized to overcome some of the undesirable side effects of rexinoids. We compared the anticarcinogenic action of LG101506 and LG100268 and for the first time showed that both drugs are useful for prevention of lung cancer in A/J mice. These molecules markedly reduced tumor number, tumor size, and total tumor burden, when chronically administered to A/J mice that had been initiated with the mutagenic carcinogen, vinyl carbamate. Moreover, LG100268 synergized with the histone deacetylase inhibitor, vorinostat, for prevention of experimental lung cancer and enhanced the effect of carboplatin/paclitaxel for treatment of experimental lung cancer. Both rexinoids diminished the percentage of high-grade, highly malignant adenocarcinomas found at autopsy. In cell culture studies, the rexinoids exhibited potent anti-inflammatory properties at nanoMolar concentrations. These drugs suppressed the ability of lipopolysaccharide to stimulate the synthesis and secretion of nitric oxide and inflammatory cytokines and chemokines, such as IL6, IL1beta, CXCL2, and CSF3, in macrophage-like RAW264.7 cells. The present results suggest that LG100268, LG101506, or a related rexinoid may have useful clinical applications in the field of oncology. Cancer Prev Res; 9(1); 105-14. (c)2015 AACR.
http://hdl.handle.net/2268/192118
(c)2015 American Association for Cancer Research.

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Cancer Prev Res-2016-Cao-105-14.pdfPublisher postprint920.73 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.